1-20 of 478
diameter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Ibrutinib in Combination with Rituximab As Frontline Treatment for Indolent Clinical Forms of Mantle Cell Lymphoma (MCL): Preliminary Results of Geltamo IMCL-2015 Phase II Trial

Eva Gine, MD, Maria de Fatima De La Cruz, MD, Carlos Grande, MD, Javier Lopez Jimenez, MD PhD, Alejandro Martín, MD PhD, Maria Jose Terol, Eva González-Barca, MD PhD, Adolfo de la Fuente, Ana Marin Niebla, PhD, Maria Casanova, MD, Ana Muntañola Prat, MD, Tomás José González-López, MD, Marta Aymerich, Lucia Palacios, MSC, Xavier Setoain, Montserrat Cortés-Romera, MD, Amanda Rotger, MD, Alejandro Medina, MD, Ramón García-Sanz, MD PhD, Elias Campo, Armando Lopez-Guillermo
Journal: Blood
Blood (2019) 134 (Supplement_1): 752.
https://doi.org/10.1182/blood-2019-122191
Published: 2019
Journal Articles

Correcting Rare Blood Disorders Using Coagulation Factors Produced In Vivo By Shielded Living Therapeutics TM Products

Guillaume Carmona, PhD, Lauren Barney, PhD, Jared Sewell, PhD, Ryan Newman, Christine Carroll, Michael Beauregard, Janet Huang, MSc, Richard W Heidebrecht, Jr., PhD, Deya Corzo, MD, David Moller, MD, Devyn Smith, PhD, David Peritt, PhD, Rogerio Vivaldi, MD MBA
Journal: Blood
Blood (2019) 134 (Supplement_1): 2065.
https://doi.org/10.1182/blood-2019-127050
Published: 2019
Journal Articles

A Biophysically Defined MSC Subpopulation for Enhanced Homing and Immunosuppression

Zhiyong Poon, Xiubo Fan, PhD, Alice Cheung, PhD, Sudipto Bari, PhD, William YK Hwang, MBBS, FRCP
Journal: Blood
Blood (2019) 134 (Supplement_1): 2078.
https://doi.org/10.1182/blood-2019-126683
Published: 2019
Journal Articles

Economic Burden of Bronchiolitis Obliterans Syndrome (BOS) Following Allogeneic Hematopoietic Stem Cell Transplant (alloHSCT) in Patients with Commercial Insurance in the United States

Naomi Sacks, PhD, Bridget Healey, MPH, Philip Cyr, MPH, Katharine Batt, MD MSc, Noreen Roth Henig, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3410.
https://doi.org/10.1182/blood-2019-127197
Published: 2019
Journal Articles

Cardiac Myosin Acts Is a Potent Procoagulant in Vitro and In Vivo

Jevgenia Zilberman-Rudenko, Hiroshi Deguchi, MD PhD, Mohammed Hayat, Meenal Shukla, PhD, Jennifer Nagrampa Orje, Zihan Guo, Tine Wyseure, PhD, Laurent O Mosnier, Owen J T McCarty, PhD, Zaverio M. Ruggeri, MD, John H. Griffin, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3632.
https://doi.org/10.1182/blood-2019-129312
Published: 2019
Journal Articles

High-Throughput Immunofluorescence and Electron Tomography to Characterize Centrosomal Aberrations in Plasma Cell Neoplasia

Tobias Dittrich, MD, Martin Schorb, Isabella Haberbosch, MD, Elena Bausch, PhD, Mandy Börmel, Marco Cosenza, PhD, Hartmut Goldschmidt, MD, Carsten Müller-Tidow, MD, Marc S Raab, MD PhD, Ute Hegenbart, MD, Stefan O. Schönland, MD, Yannick Schwab, PhD, Alwin Krämer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3077.
https://doi.org/10.1182/blood-2019-130713
Published: 2019
Journal Articles

A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma

Anita Kumar, MD, Carla Casulo, Ranjana H Advani, MD, Lihua E Budde, MD PhD, Paul M. Barr, MD, Connie Lee Batlevi, MD PhD, Philip Caron, MD PhD, Louis S. Constine, MD, Savita Dandapani, MD PhD, Esther Drill, PhD, Pamela Drullinsky, MD, Jonathan W. Friedberg, MD, Clare Grieve, BA, Audrey Hamilton, MD, Paul A. Hamlin, MD, Richard T Hoppe, MD, Steven M. Horwitz, MD, Matthew J Matasar, MD, Susan Jennifer McCall, NP, Alison J. Moskowitz, MD, Ariela Noy, MD, Maria Lia Palomba, MD, Heiko Schoder, MD, David J. Straus, MD, Shreya Vemuri, Joanna C Yang, MD MPH, Anas Younes, MD, Andrew D. Zelenetz, MD PhD, Joachim Yahalom, MD, Craig H. Moskowitz
Journal: Blood
Blood (2019) 134 (Supplement_1): 2834.
https://doi.org/10.1182/blood-2019-123150
Published: 2019
Journal Articles

Fast Onset of Action of Subcutaneously Administered Marzeptacog Alfa (Activated) Supports on-Demand Treatment in Hemophilia a Mice

Frank Del Greco, MBA, Linda Neuman, MD, Howard Levy, PhD MBBChir, Jill Reckless, Tom Knudsen, PhD DVM, Grant E. Blouse, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2420.
https://doi.org/10.1182/blood-2019-128971
Published: 2019
Journal Articles

Myeloma Derived Extracellular Vesicles Containing Endoplasmic Reticulum Remodel the Bone Marrow Microenvironment Towards a Pro-Tumoral Senescent Phenotype

Yu Sun, BSc, MSc, PhD, Jayna J Mistry, BSc, Jamie A Moore, BSc, MSc, Charlotte Hellmich, MBBChir, Christopher R Marlein, PhD, Anna Haestier, Cesar A. Gomez, MD PhD FRCPath, Christopher J Morris, PhD, Kristian M Bowles, MBBS, PhD, Stuart A Rushworth, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 689.
https://doi.org/10.1182/blood-2019-128268
Published: 2019
Journal Articles

Phase-I Study of ETA Receptor Antagonist Ambrisentan in Sickle Cell Disease

Abdullah Kutlar, MD, Jennifer Pollock, PhD, Steffen E. Meiler, MD, Ryan Harris, PhD CEP, FACSM, Xu Hongyan, PhD, Leigh Wells, MSN, Latanya Bowman, RN, Sharon Jones, BS, David M. Pollock, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 617.
https://doi.org/10.1182/blood-2019-130036
Published: 2019
Journal Articles

Updated Results from the German Mpnsg-0212 Combination Trial: Ruxolitinib Plus Pomalidomide in Myelofibrosis with Anemia

Frank Stegelmann, MD, Steffen Koschmieder, Susanne Isfort, Andreas Hochhaus, MD, Florian H. Heidel, Holger Hebart, Markus Bangerter, Denise Wolleschak, Christoph Scheid, MD, Joachim R Göthert, PD, MD, Philippe Schafhausen, Thomas Kindler, MD, Markus P. Radsak, MD, Robert Möhle, MD, Cornelius Waller, Nikolas von Bubnoff, Andreas Reiter, Hartmut Döhner, MD, Martin Griesshammer, MD, Konstanze Döhner
Journal: Blood
Blood (2019) 134 (Supplement_1): 672.
https://doi.org/10.1182/blood-2019-127859
Published: 2019
Journal Articles

Beyond PD-1: Investigating the Therapeutic Potential of TIGIT Blockade in DLBCL

Nicole Sunseri, MD PhD, Xiufen Chen, PhD, Noemie Wald, PhD, Julie Preillon, PhD, Sonali M. Smith, MD, Gregory Driessens, PhD, Justin Kline, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 391.
https://doi.org/10.1182/blood-2019-131493
Published: 2019
Journal Articles

Prevention of Bleeding-Induced Vascular Abnormalities in the Hemophilic Mouse Joint By Increasing TAFI Levels or Inhibiting uPA Activity

Tine Wyseure, PhD, Niels Behrendt, Annette von Drygalski, MD PharmD, Laurent O Mosnier
Journal: Blood
Blood (2019) 134 (Supplement_1): 158.
https://doi.org/10.1182/blood-2019-128723
Published: 2019
Journal Articles

Transcriptional and Spatial Heterogeneity of Mouse Megakaryocytes at Single-Cell Resolution

Shu Sun, BS, Chen Jin, PhD, Yueying Li, MD, Jia Si, Yueli Cui, Matthew T. Rondina, MD, Fuchou Tang, PhD, Qian-fei Wang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 275.
https://doi.org/10.1182/blood-2019-129471
Published: 2019
Journal Articles

EPCR Deficiency Prevents Development of Hemophilic Arthropathy

Jhansi Magisetty, PhD MSc, Usha Pendurthi, PhD, Charles T. Esmon, PhD, L. Vijaya Mohan Rao, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 159.
https://doi.org/10.1182/blood-2019-124972
Published: 2019
Journal Articles

Should a Bulky Mediastinal Mass ≥7cm in the Longest Dimension be Considered an Adverse Prognostic Factor in Patients with Advanced Hodgkin Lymphoma and Negative Interim PET/CT?

Eldad J Dann, MD, Rebeca Lopez-Alonso, Shunan Qi, Tania Mashiach, Michal Weiler-Sagie, Joachim Yahalom, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4051.
https://doi.org/10.1182/blood-2019-122824
Published: 2019
Journal Articles

Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase 2 Study

N. Nora Bennani, MD, Grzegorz Nowakowski, MD, Lisa M. Rimsza, MD, Alex A Adjei, MD PhD, Laurence Doyle, Stephen M Ansell, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4090.
https://doi.org/10.1182/blood-2019-129104
Published: 2019
Journal Articles

A Phase 1a/1b Trial of ST-001, a Fenretinide Phospholipid Suspension for 4-Hour Intravenous Infusion in Relapsed/Refractory T-Cell Non-Hodgkin's Lymphoma

Ayad Al-Katib, MD, Timothy M. Kuzel, MD, Ralph Parchment, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4041.
https://doi.org/10.1182/blood-2019-127278
Published: 2019
Journal Articles

Efficacy and Safety of PD-1 Inhibitor Plus GVD Chemotherapy in Patients with Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (rrPMLBCL)

Qian Mei, PhD, Wenying Zhang, MD, Yang Liu, MD, Qingming Yang, MD, John E.J. Rasko, MBBS, PhD, Weidong Han, PhD MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4072.
https://doi.org/10.1182/blood-2019-121768
Published: 2019
Journal Articles

Prediction of High-Risk Group of Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using a CT-Based Radiomics Model with Machine Learning

Raoul Santiago, MDMSc, Johanna Ortiz Jimenez, MD, Reza Forghani, MD PhD, Nikesh Muthukrishnan, MEng, Olivier Del Corpo, BSC, MSc, Shairabi Karthigesu, Muhammad Yahya Haider, Caroline Reinhold, MD MSc, Sarit Assouline, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4136.
https://doi.org/10.1182/blood-2019-126745
Published: 2019